Ryan D. Maynard, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 7,500 shares at $6.75 ($51K) on 2022-05-31, disclosed to the SEC on 2022-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| RIGL | SELL | 2017-11-07 | $390K | — | Filing → |
| RIGL | SELL | 2012-09-14 | $249K | — | Filing → |
| RIGL | SELL | 2012-09-14 | $249K | — | Filing → |